| |
| |
|
| Insider
Information: |
Maclean Michael F |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
102,774 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,334,148 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
102,774 |
|
|
| Total
Value |
$4,334,148 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 10.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
SVP, Chief Accounting ... |
2010-10-01 |
10,681 |
2007-02-12 |
0 |
Premium* |
|
|
Akcea Therapeutics Inc |
AKCA |
Chief Financial Officer |
2020-01-15 |
48,000 |
2019-09-19 |
0 |
Premium* |
|
|
Avidity Biosciences, Inc. |
RNA |
|
2024-05-14 |
44,093 |
2023-01-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
SVP, Chief Accounting Officer |
• – – |
2009-02-12 |
4 |
D |
$52.61 |
$105,588 |
D/D |
(2,007) |
20,570 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Chief Accounting Officer |
• – – |
2010-02-12 |
4 |
D |
$55.21 |
$110,530 |
D/D |
(2,002) |
21,259 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Chief Accounting Officer |
• – – |
2008-07-31 |
4 |
AS |
$72.77 |
$136,444 |
D/D |
(1,875) |
24,895 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Chief Accounting Officer |
• – – |
2008-04-08 |
4 |
AS |
$63.52 |
$142,508 |
D/D |
(2,214) |
25,577 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Chief Accounting Officer |
• – – |
2010-03-19 |
4/A |
AS |
$60.00 |
$225,420 |
D/D |
(3,757) |
20,642 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Chief Accounting Officer |
• – – |
2010-03-19 |
4 |
AS |
$60.00 |
$245,100 |
D/D |
(4,085) |
20,314 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Financial Officer |
• – – |
2024-03-13 |
4 |
OE |
$8.82 |
$352,800 |
D/D |
40,000 |
84,093 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
SVP, Chief Accounting Officer |
• – – |
2010-08-02 |
4 |
AS |
$56.83 |
$542,457 |
D/D |
(9,542) |
11,634 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Financial Officer |
• – – |
2024-05-14 |
4 |
OE |
$8.82 |
$661,500 |
D/D |
75,000 |
119,093 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Financial Officer |
• – – |
2024-03-13 |
4 |
S |
$24.52 |
$980,760 |
D/D |
(40,000) |
44,093 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Financial Officer |
• – – |
2024-05-14 |
4 |
AS |
$28.28 |
$2,121,045 |
D/D |
(75,000) |
44,093 |
0 |
% |
|
36 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
